NCT00263601View on ClinicalTrials.gov

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

May 31, 2004

Study Completion Date

August 31, 2010

Conditions
Grass Pollen Allergy
Interventions
BIOLOGICAL

Allergovit 6-grasses

Subcutaneous injections

OTHER

Placebo

Subcutaneous injections

Trial Locations (1)

21465

Allergopharma GmbH & Co. KG, Reinbek

All Listed Sponsors
lead

Allergopharma GmbH & Co. KG

INDUSTRY

NCT00263601 - Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter